BCOP Updates 2025: Becoming Comfortable in the Gray (Gy) - Radiation Oncology for Pharmacists

As radiation therapy evolves, pharmacists must be more aware of this treatment modality for managing cancer patients. Traditional external beam therapies and toxicities will be discussed as well as emerging modalities such as proton therapy, stereotactic therapy, and radiopharmaceuticals. The common and more serious adverse events will be reviewed. A mention of patient counseling for post-radiopharmaceutical management and monitoring will be reviewed for all current FDA-approved radiopharmaceuticals. Focus on the multidisciplinary approach to the management of these patients will be discussed. Finally, the presentation will review the role of the pharmacist in the care of patients undergoing a combination of systemic therapy and radiation therapy with a focus on outcomes and management of radiation-specific toxicities, especially in the metastatic disease setting.